Based on these results, scientists at Tokushima University Hospital and Suzuka University of Medical Science, in Japan, conducted a long-term Phase 2/3 clinical trial (NCT00444613) to evaluate the efficacy and safety of ultra-high-dose methylcobalamin treatment for ALS
Vitamin B12 deficiency in an infant with neurological and hematological findings: A case report
Thats where the real danger lives, and thats where the enforcement belongs
Many of this studys subjects also had ligament sprains and tendon issues, which often heal on their own over time, so its unclear if these improvements were due to the peptide or just the passage of time (the study had no control group)
Click here for SDS Active Ingredients: Each mL contains: Cyanocobalamin (B12) 3,000 mcg Sodium chloride 0.9% w/v Ammonium sulfate 0.1% w/v Citric acid 0.01% w/v Sodium citrate 0.008% w/v Benzyl alcohol (preservative) 1.5% v/v Indications: For use as an aid in the management of vitamin B12 deficiencies in horses, dogs and cats